نتایج جستجو برای: neurotherapeutics

تعداد نتایج: 127  

2005
Kenneth Marek John Seibyl

Neuroimaging has provided insight into the pathophysiology and natural history of Parkinson’s disease (PD) and has emerged as a tool to monitor disease progression and to assess new potentially neuroprotective or neurorestorative therapies for PD. Diverse imaging methods have been successfully applied to neurological disorders. While technology like functional magnetic resonance imaging or magn...

Journal: :Neuron 2015
Sydney S. Cash Leigh R. Hochberg

Single neuron actions and interactions are the sine qua non of brain function, and nearly all diseases and injuries of the CNS trace their clinical sequelae to neuronal dysfunction or failure. Remarkably, discussion of neuronal activity is largely absent in clinical neuroscience. Advances in neurotechnology and computational capabilities, accompanied by shifts in theoretical frameworks, have le...

Journal: :Annals of neurology 2013
Joseph R Berger Dennis Choi Henry J Kaminski Mark F Gordon Orest Hurko O'Neill D'Cruz Samuel J Pleasure Eva L Feldman

This is a critical time in neurotherapeutics. The prevalence of neurological disease, such as dementia, stroke, and peripheral neuropathy, is large and growing consequent to the aging population. The personal and societal impact of these disorders is enormous, and the number of novel therapies in the pipeline for these disorders has been contracting. Support for the development of neurotherapie...

2014
Christopher L. Cioffi Nicoleta Dobri Emily E. Freeman Michael P. Conlon Ping Chen Douglas G. Stafford Daniel M. C. Schwarz Kathy C. Golden Lei Zhu Douglas B. Kitchen Keith D. Barnes Boglarka Racz Qiong Qin Enrique Michelotti Charles L. Cywin William H. Martin Paul G. Pearson Graham Johnson Konstantin Petrukhin

Accumulation of lipofuscin in the retina is associated with pathogenesis of atrophic age-related macular degeneration and Stargardt disease. Lipofuscin bisretinoids (exemplified by N-retinylidene-N-retinylethanolamine) seem to mediate lipofuscin toxicity. Synthesis of lipofuscin bisretinoids depends on the influx of retinol from serum to the retina. Compounds antagonizing the retinol-dependent ...

Journal: :The Lancet. Neurology 2008
Edward Neuwelt N Joan Abbott Lauren Abrey William A Banks Brian Blakley Thomas Davis Britta Engelhardt Paula Grammas Maiken Nedergaard John Nutt William Pardridge Gary A Rosenberg Quentin Smith Lester R Drewes

There is a paucity of therapies for most neurological disorders--from rare lysosomal storage diseases to major public health concerns such as stroke and Alzheimer's disease. Advances in the targeting of drugs to the CNS are essential for the future success of neurotherapeutics; however, the delivery of many potentially therapeutic and diagnostic compounds to specific areas of the brain is restr...

2012
Ethan S. Lippmann Samira M. Azarin Jennifer E. Kay Randy A. Nessler Hannah K. Wilson Abraham Al-Ahmad Sean P. Palecek Eric V. Shusta

The blood-brain barrier (BBB) is crucial to the health of the brain and is often compromised in neurological disease. Moreover, because of its barrier properties, this endothelial interface restricts uptake of neurotherapeutics. Thus, a renewable source of human BBB endothelium could spur brain research and pharmaceutical development. Here we show that endothelial cells derived from human pluri...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید